ToniDubeauNP

PubMed

• 11 citations
  Low risk of Pneumocystis jirovecii pneumonia and invasive aspergillosis in patients with Waldenström macroglobulinaemia on ibrutinib.
  Matthew P. Cheng, Joshua Gustine, Scott Dryden-Peterson, Toni Dubeau, Ann E. Woolley, Sarah P. Hammond, Lindsey R. Baden, Steven P. Treon, Jorge J. Castillo, Nicolas C...> ;British Journal of Haematology. 2019 May 1
• 4 citations
  Long survival in patients with Waldenström macroglobulinaemia diagnosed at a young age
  Amaara Babwah, Joshua Gustine, Kirsten Meid, Toni Dubeau, Lian Xu, Guang Yang, Zachary R. Hunter, Steven P. Treon, Jorge J. Castillo> ;British Journal of Haematology. 2019 May 1
• 28 citations
  TP53 mutations are associated with mutated MYD88 and CXCR4, and confer an adverse outcome in Waldenström macroglobulinaemia
  Joshua Gustine, Nicholas Tsakmaklis, Maria Demos, Amanda Kofides, Jiaji G. Chen, Xia Liu, Manit Munshi, Maria Luisa Guerrera, Gloria Chan, C. J. Patterson, Kirsten Mei...> ;British Journal of Haematology. 2019 Jan 1
• 49 citations
  Ibrutinib discontinuation in Waldenström macroglobulinemia: Etiologies, outcomes, and IgM rebound
  Joshua Gustine, Kirsten Meid, Toni Dubeau, Patricia Severns, Zachary R. Hunter, Yang Guang, Lian Xu, Steven P. Treon, Jorge J. Castillo> ;American Journal of Hematology. 2018 Aug 1
• Impact of Ibrutinib Dose Intensity on Patient Outcomes in Previously Treated Waldenström Macroglobulinemia
  Jorge J Castillo, Toni E Dubeau, Steven P Treon, Ranjana Advani> ;Haematologica.
• 35 citations
  Response and survival for primary therapy combination regimens and maintenance rituximab in Waldenström macroglobulinaemia.
  Jorge J. Castillo, Joshua Gustine, Kirsten Meid, Toni Dubeau, Patricia Severns, Lian Xu, Guang Yang, Zachary R. Hunter, Steven P. Treon> ;British Journal of Haematology. 2018 Apr 1
• 41 citations
  Ibrutinib withdrawal symptoms in patients with Waldenström macroglobulinemia.
  Jorge J. Castillo, Joshua Gustine, Kirsten Meid, Toni Dubeau, Patricia Severns, Steven P. Treon> ;Haematologica. 2018 Feb 22
• 64 citations
  MYD88 wild-type Waldenstrom Macroglobulinaemia: differential diagnosis, risk of histological transformation, and overall survival.
  , , , , , , , , , , , , , , , , , > ;British Journal of Haematology. 2018 Feb 1
• 56 citations
  BTKCys481Ser drives ibrutinib resistance via ERK1/2 and protects BTKwild-type MYD88-mutated cells by a paracrine mechanism.
  Jiaji G. Chen, Xia Liu, Manit Munshi, Lian Xu, Nicholas Tsakmaklis, Maria Demos, Amanda Kofides, Maria Luisa Guerrera, Gloria Chan, Christopher J. Patterson, Kirsten M...> ;Blood. 2018 May 3
• 48 citations
  Serum IgM level as predictor of symptomatic hyperviscosity in patients with Waldenström macroglobulinaemia.
  Joshua Gustine, Kirsten Meid, Toni Dubeau, Zachary R. Hunter, Lian Xu, Guang Yang, Irene M. Ghobrial, Steven P. Treon, Jorge J. Castillo> ;British Journal of Haematology. 2017 May 9
• 98 citations
  Acquired mutations associated with ibrutinib resistance in Waldenström macroglobulinemia.
  Lian Xu, Nicholas Tsakmaklis, Guang Yang, Jiaji G. Chen, Xia Liu, Maria Demos, Amanda Kofides, Christopher J. Patterson, Kirsten Meid, Joshua Gustine, Toni Dubeau, M. ...> ;Blood. 2017 May 4
• 49 citations
  Renal disease related to Waldenström macroglobulinaemia: incidence, pathology and clinical outcomes.
  Josephine M.I. Vos, Joshua Gustine, Helmut G. Rennke, Zachary R. Hunter, Robert Manning, Toni Dubeau, Kirsten Meid, Monique C. Minnema, Marie-Jose Kersten, Steven P. T...> ;British Journal of Haematology. 2016 Jul 29
• Join now to see all

Journal Articles

• TP53 Mutations Are Associated with Mutated MYD88 and CXCR4, and Confer an Adverse Outcome in Waldenström Macroglobulinaemia  
  Toni Dubeau, Steven P Treon, Jorge J Castillo, Christopher J Patterson, British Journal of Haematology